Blood News and Research

RSS

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a new SARS-CoV-2 neutralizing antibody.

18 Dec 2020

UVA researcher evaluates a new approach to managing type 2 diabetes

A researcher at the University of Virginia School of Medicine is testing what he calls a "radically different" approach to managing type 2 diabetes for those who can't or don't want to lose weight.

18 Dec 2020

No more ICU beds at the main public hospital in the nation’s largest county as COVID surges

She lay behind a glass barrier, heavily sedated, kept alive by a machine that blew oxygen into her lungs through a tube taped to her mouth and lodged at the back of her throat. She had deteriorated rapidly since arriving a short time earlier.

18 Dec 2020

Researchers to explore new ways to diagnose early-stage lung cancer

Ground-breaking medical research in a consortium led by two UK universities will explore new ways to diagnose lung cancer earlier and save lives.

18 Dec 2020

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.

18 Dec 2020

Cell atlas helps better understand the biology of tropical disease parasite

The first cell atlas of an important life stage of Schistosoma mansoni, a parasitic worm that poses a risk to hundreds of millions of people each year, has been developed by researchers at the Wellcome Sanger Institute and their collaborators.

18 Dec 2020

Could neurological complications be common even in mild COVID-19?

News-Medical talks to Dr. Pria Anand about her research into COVID-19 that suggests neurologic complications are common even in mild infections.

18 Dec 2020

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Abbott announced today it received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test.

18 Dec 2020

Researchers develop new nanoparticle that efficiently and selectively kills cancer cells

Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have developed a novel type of nanoparticle that efficiently and selectively kills cancer cells, thus opening up new therapeutic options for the treatment of tumors.

18 Dec 2020

Novel device may help restore total eye function

An international consortium of researchers is developing a new method to bring eyes back to life from deceased body donors for clinical research purposes.

18 Dec 2020

Hearing loss, high blood sugar linked to poor cognitive performance among older Latinos

Hearing loss and diabetes are major public health problems, with Latinos at higher risk than other demographic groups.

18 Dec 2020

Research examines processes of lung scarring and chronic rejection of organ after transplantation

Two new papers examine the processes of lung scarring and chronic rejection of the organ after transplantation, and potential therapies to stop the graft, or transplanted organ and its tissue, from failing.

17 Dec 2020

Research shows that people affected with COVID-19 suffer from cognitive effects

More and more evidence is coming out that people with COVID-19 are suffering from cognitive effects, such as brain fog and fatigue.

17 Dec 2020

Researchers are developing new criteria for clinical research of antiphospholipid syndrome

An international team of more than 80 collaborators led by Hospital for Special Surgery (HSS) investigators is developing new classification criteria for clinical research of antiphospholipid syndrome (APS), a life-threatening autoimmune clotting disorder.

17 Dec 2020

New toolkit aims to maximize high-quality collection of thrombosis data in COVID-19 clinical studies

The ASH Research Collaborative and the International Society of Haemostasis and Thrombosis, two organizations with multidisciplinary expertise in blood clotting and bleeding disorders, have developed a toolkit to help clinical researchers from across medical disciplines design clinical trials that further the understanding of blood clotting events associated with COVID-19.

17 Dec 2020

New prognostic tool predicts the need for ICU among COVID-19 patients

Researchers in the UK have developed a prognostic tool that accurately predicts whether patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent causes coronavirus disease 2019 (COVID-19) – will require admission to the intensive care unit (ICU), die, or survive without escalation to ICU.

17 Dec 2020

Fish oil supplements not associated with increases in bad cholesterol

The Fatty Acid Research Institute has published a new research paper in conjunction with The Cooper Institute on the omega-3s EPA and DHA in fish oil and low density lipoprotein cholesterol (LDL-C).

17 Dec 2020

Study shows impact of the pandemic on lung cancer screening

When the pandemic hit the U.S. in early 2020, many routine activities came to a halt.

17 Dec 2020

Study shows benefits of integrated palliative and oncology care for patients with advanced AML

A first-of-its-kind intervention integrating palliative care early in the course of cancer therapy for patients with advanced acute myeloid leukemia (AML), a highly aggressive cancer of the blood and bone marrow, resulted in substantial improvements in patients' quality of life, mood and end-of-life care, a team of investigators has found.

17 Dec 2020

BU researchers awarded $2.4 million NIH grant to study idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a serious chronic disease that affects the tissue surrounding the air sacs in the lungs.

17 Dec 2020

Blood News and Research

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

UVA researcher evaluates a new approach to managing type 2 diabetes

No more ICU beds at the main public hospital in the nation’s largest county as COVID surges

Researchers to explore new ways to diagnose early-stage lung cancer

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

Cell atlas helps better understand the biology of tropical disease parasite

Could neurological complications be common even in mild COVID-19?

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Researchers develop new nanoparticle that efficiently and selectively kills cancer cells

Novel device may help restore total eye function

Hearing loss, high blood sugar linked to poor cognitive performance among older Latinos

Research examines processes of lung scarring and chronic rejection of organ after transplantation

Research shows that people affected with COVID-19 suffer from cognitive effects

Researchers are developing new criteria for clinical research of antiphospholipid syndrome

New toolkit aims to maximize high-quality collection of thrombosis data in COVID-19 clinical studies

New prognostic tool predicts the need for ICU among COVID-19 patients

Fish oil supplements not associated with increases in bad cholesterol

Study shows impact of the pandemic on lung cancer screening

Study shows benefits of integrated palliative and oncology care for patients with advanced AML

BU researchers awarded $2.4 million NIH grant to study idiopathic pulmonary fibrosis

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News